BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Business

  Hologic Announces Financial Results for Fourth Quarter of Fiscal 2019

  Hologic, Inc. announced the Company’s financial results for the fiscal fourth quarter ended September 28, 2019.

  November 6, 2019

   · 

  30 min read
• Business

  ARCA Biopharma Announces Third Quarter 2019 Financial Results and Provides Corporate Update

  ARCA biopharma, Inc., a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, reported financial results for the quarter ended September 30, 2019 and provided a corporate update.

  November 6, 2019

   · 

  7 min read
• Business

  Globus Medical Reports Third Quarter 2019 Results

  Globus Medical, Inc., a leading musculoskeletal solutions company, announced its financial results for the third quarter ended September 30, 2019.

  November 6, 2019

   · 

  17 min read
• Business

  Nevro Reports Third Quarter 2019 Financial Results

  Company Raises 2019 Guidance, Announces CFO Retirement Plans Third Quarter 2019 and Recent Highlights

  November 6, 2019

   · 

  11 min read
• Business

  Aimmune Therapeutics Announces Third Quarter 2019 Financial Results and Provides Operational Highlights

  Aimmune Therapeutics, Inc., a biopharmaceutical company developing treatments for potentially life-threatening food allergies, announced financial results for the quarter and nine months ended September 30, 2019 and provided operational highlights.

  November 6, 2019

   · 

  12 min read
• Business

  Glaukos Corporation Announces Third Quarter 2019 Financial Results

  Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced financial results for the third quarter ended September 30, 2019.

  November 6, 2019

   · 

  15 min read
• Job Trends

  Final Five Unpublished Late-Breaking Clinical Trial Results Announced at VIVA19

  VIVA Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the final round of 21 highly anticipated late-breaking clinical trial results at VIVA19 hosted at Wynn Las Vegas.

  November 6, 2019

   · 

  9 min read
• Business

  TherapeuticsMD Announces Third Quarter 2019 Financial Results

  TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women’s healthcare company, today reported financial results for the third quarter ended September 30, 2019 and provided a business update.

  November 6, 2019

   · 

  15 min read
• Deals

  LHC Group Announces Third Quarter 2019 Financial Results

  LHC Group, Inc. announced its financial results for the quarter ended September 30, 2019.

  November 6, 2019

   · 

  28 min read
• Drug Development

  Camallergy Provides Corporate Update and Prepares to Advance Lead Candidate CA002 Into Phase 3 Efficacy Trial for Peanut Allergy

  Cambridge Allergy Ltd, a biopharmaceutical company dedicated to providing innovative, patient-centric treatments for life-threatening food allergies, provided a corporate update, including recent progress with its development of CA002 for the treatment of peanut allergy.

  November 6, 2019

   · 

  4 min read